Determinants of passive antibody efficacy in SARS-CoV-2 infection: a systematic review and meta-analysis
Description
BACKGROUND: Randomised controlled trials of passive antibodies as treatment and prophylaxis for COVID-19 have reported variable efficacy. However, the determinants of efficacy have not been identified. We aimed to assess how the dose and timing of
